Berlin - Delayed Quote EUR
Liquidia Corp (LT4.BE)
14.25
+0.35
+(2.52%)
At close: May 5 at 9:52:05 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
13,996
13,996
17,488
15,935
12,853
Cost of Revenue
5,879
5,879
2,888
2,859
3,023
Gross Profit
8,117
8,117
14,600
13,076
9,830
Operating Expense
129,411
129,411
87,984
51,846
43,627
Operating Income
-121,294
-121,294
-73,384
-38,770
-33,797
Net Non Operating Interest Income Expense
-4,832
-4,832
-2,807
-1,248
-729
Other Income Expense
-4,268
-4,268
-2,311
-997
-53
Pretax Income
-130,394
-130,394
-78,502
-41,015
-34,579
Net Income Common Stockholders
-130,394
-130,394
-78,502
-41,015
-34,579
Diluted NI Available to Com Stockholders
-130,394
-130,394
-78,502
-41,015
-34,579
Basic EPS
-1.62
-1.66
-1.21
-0.67
-0.70
Diluted EPS
-1.62
-1.66
-1.21
-0.67
-0.70
Basic Average Shares
73,957.55
78,707.50
64,993.48
60,958.86
49,677.74
Diluted Average Shares
73,957.55
78,707.50
64,993.48
60,958.86
49,677.74
Total Operating Income as Reported
-121,294
-121,294
-73,384
-38,770
-33,797
Total Expenses
135,290
135,290
90,872
54,705
46,650
Net Income from Continuing & Discontinued Operation
-130,394
-130,394
-78,502
-41,015
-34,579
Normalized Income
-126,126
-126,126
-76,191
-40,018
-34,526
Interest Income
7,654
7,654
3,466
1,090
33
Interest Expense
12,486
12,486
6,273
2,338
762
Net Interest Income
-4,832
-4,832
-2,807
-1,248
-729
EBIT
-117,908
-117,908
-72,229
-38,677
-33,817
EBITDA
-115,711
-115,711
-70,051
-35,030
-28,205
Reconciled Cost of Revenue
5,879
5,879
2,888
2,859
3,023
Reconciled Depreciation
2,197
2,197
2,178
3,647
5,612
Net Income from Continuing Operation Net Minority Interest
-130,394
-130,394
-78,502
-41,015
-34,579
Total Unusual Items Excluding Goodwill
-4,268
-4,268
-2,311
-997
-53
Total Unusual Items
-4,268
-4,268
-2,311
-997
-53
Normalized EBITDA
-111,443
-111,443
-67,740
-34,033
-28,152
12/31/2021 - 10/22/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
D01.SG Belite Bio Inc
54.50
0.00%
ATQP.F Vericel Corporation
34.00
+1.80%
A71.F Ascendis Pharma A/S
154.00
+5.48%
PTCT PTC Therapeutics, Inc.
40.65
-18.62%
RPTX Repare Therapeutics Inc.
1.4000
-2.10%
SLNO Soleno Therapeutics, Inc.
76.49
+1.67%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.3700
+3.95%
SRPT Sarepta Therapeutics, Inc.
63.66
+0.24%
PRTG Portage Biotech Inc.
9.81
-4.48%
VRTX Vertex Pharmaceuticals Incorporated
500.19
-0.19%